Zepbound Vials: The Business Case

Send a text

Dave Knapp makes the business case for why Eli Lilly won’t simply release the vials - they have to.

Email Alerts: https://www.onthepen.com/emails

BECOME A MEMBER HERE TO WATCH THE VIDEO:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

Bloomberg #ReleaseTheVials Feature:
https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supply

Yahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQbYa47DF4Q?feature=shared

#mounjaro #zepbound #tirzepatide

Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

🤝 Visit Our Sponsors!
OTPLinks.com

Decoding GLP-1 Book
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
Buy Here: https://amzn.to/3Dc66d4

MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
Venmo: OnThePen
Ca$h App: ManOnMounjaro

BECOME A MEMBER:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

👉 My Amazon Affiliate Store:
https://www.amazon.com/shop/manonthemounjaroonthepen

WATCH MORE!
📺 We're Live M/W/F at 11 central: onthepen.tv

📲 Contact Me: dave@onthepen.com

Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.